Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SX600 for lumbar radiculopathy
NCT03952377Phase 2Terminated
- Sponsor
- SpineThera
- Start
- Nov 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone acetate extended-release microspheres in lumbar radiculopathy (3 arms), sponsored by SpineThera. Primary endpoint: Proportion of Subjects With a 50% or Greater Improvement in Mean Worst Daily Leg Pain at 60 days. Started Nov 2019; status: terminated.
02
Drugs
dexamethasone acetate extended-release microspheres
03
Conditions
lumbar radiculopathy
Beyond the preview
Go deeper on NCT03952377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03952377.